Cramer's 'Mad Money' Recap: July 1

07/01/08 - 07:44 PM EDT

, MDRX , RMD , BRS , HOS , APC , NBR , RIG , NFX  
Scott Rutt

Click here for an archive of Cramer's "Mad Money" recaps.


"Today we saw leadership from a group that's been hated all year," Jim Cramer told viewers of his "Mad Money" TV show Tuesday.

Healthcare stocks, he said, are on the ascent because they stand to benefit from the upcoming Medicare spending bill that will give investors a unique opportunity "to have the wind at their backs."

According to Cramer, the new Medicare spending bill now provides incentives for using electronic prescriptions, as opposed to paper, through 2010, and mandates electronic prescriptions thereafter. The provisions, now in both the House and Senate versions of the bill, will be a windfall for Allscripts(MDRX Quote - Cramer on MDRX - Stock Picks), a company with a lock in the e-prescription business, he said.

Allscripts currently has a client base of 150,000 doctors, nearly one quarter of all the doctors in the U.S., along with 700 hospitals. Yet, Cramer noted only 2% of prescriptions were sent electronically in 2007, leaving a huge market for Allscripts to tap. The company's ERX software provides doctors with a free way to start sending prescriptions electronically with no upfront costs.

Shares of Allscripts have been hit hard in recent months due to bugs in their electronic healthcare platform and what Cramer called overall poor execution. But the management has proclaimed the platform ready for prime time. Cramer said now is the time to invest in the company, especially with electronic prescriptions expected to grow 400% in 2008.

Cramer: What Merrill Upgrade Means for XM-SIRI
« Previous Page
1 2
Your Recent Quotes: Quote Up0 | Quote Down0
Dow S&P 500 NASDAQ
Oil*
Gold
10 Yr
0.00%
%
%
%
Data delayed 20 min
Free Newsletters from TheStreet

Cramer's Daily Booyah!
Highlights of Jim Cramer's videos
on TheStreet.com TV & his
"Mad Money" TV show.
Before the Bell
All the information you
need to position yourself
for the day ahead.
Submit
We respect your privacy.

Premium Stock Ideas
Access Action Alerts Plus to find out Cramer’s latest picks now!